Cedars-Sinai Discovery May Aid Doctors in Diagnosing At-risk Patients Before Symptoms Appear
A team led by a Cedars-Sinai physician-scientist has discovered a biomarker—a protein found in the blood—for the most common type of heart failure, a new study published today in JAMA Cardiology shows.
Heart failure with preserved ejection fraction (HFpEF) affects more than 6.5 million Americans each year. And now, thanks to the discovery of the first-ever biomarker for HFpEF, a simple blood test can reveal whether a patient’s heart is not making enough of an important protein. If the protein levels are decreased, the biomarker signal increases and physicians will be able to diagnose heart failure sooner, prescribe corrective medicines and prevent further disease progression.
“By the time heart failure symptoms develop, the critical window for corrective therapy has typically closed,” said Robin Shaw, MD, PhD, the Wasserman Endowed Chair in Cardiology and professor of Medicine at the Smidt Heart Institute at Cedars-Sinai and principal investigator on the study. “Our discovery allows us to not only diagnose the disease sooner, but also to treat patients before that critical period of early intervention for lifesaving care has closed.”
Heart failure with preserved ejection fraction is a condition where the heart can contract, but has problems relaxing—limiting the heart’s ability to fill with blood between each beat—and therefore lowers the amount of blood moving forward with each contraction. Prior to the discovery of the biomarker, clinicians had to wait for patients to have symptoms to make a diagnosis of HFpEF and had to use an echocardiogram that measured how well the heart relaxed. There was no method to gauge the health of the heart muscle before symptoms developed or determine the severity of disease once symptoms were present.
The biomarker—named cBIN1 Score, or CS for short—allows doctors to measure muscle deterioration and measure a protein that regulates the heart’s ability to both contract and relax. As the protein decreases, CS increases, serving as an indication of onset heart failure. The CS biomarker can be measured using a simple blood draw.
This discovery will allow the most at-risk patients—including older patients and patients with high blood pressure, diabetes or dyslipidemia—to be checked during an annual exam from their primary care physician. This pivotal research has the potential to impact millions of people and serve as a critical tool for preventive heart care.
Eduardo Marbán, MD, PhD, director, Smidt Heart Institute
The CS biomarker is designed to be used in an outpatient clinic setting. For patients with known HFpEF, doctors can draw a CS level and use it to both guide current care, including medication adjustments, and predict the chances of a patient being admitted to the hospital in the next 12 months.
“More broadly, this discovery will allow the most at-risk patients—including older patients and patients with high blood pressure, diabetes or dyslipidemia—to be checked during an annual exam from their primary care physician,” said Eduardo Marbán, MD, PhD, director of the Smidt Heart Institute. “This pivotal research has the potential to impact millions of people and serve as a critical tool for preventive heart care.”
Symptoms of heart failure typically appear as fatigue, fluid weight gain, leg swelling and shortness of breath. Heart failure with preserved ejection fraction is typically diagnosed in elderly people or those living with high blood pressure, diabetes, elevated cholesterol, hypertension, obesity, obstructive sleep apnea, anemia, iron deficiency or diabetes. Its prevalence is projected to rise drastically over the coming decades. Previous studies have shown that women represent the majority of patients diagnosed with the disease.
As next steps, Cedars-Sinai researchers plan on identifying specialty populations in which the CS biomarker could be useful, including sex-based differences, those who have undergone a heart transplant or valve replacement, as well as individuals with no known heart disease or risk factors.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Koreaon June 25, 2020 at 2:29 am
In this study using national health insurance data, we investigated the risk of ischemic heart disease (IHD) and stroke among prostate cancer (PC) survivors compared with the general population, as ...
- Acute Heart Failure, Hemoglobin Decrease Associated With Worse Outcome in Recent Studyon June 24, 2020 at 12:42 pm
A worse prognosis in patients with heart failure has possibly been linked to having at least 1 anemic episode, or a drop in hemoglobin levels, as was a greater risk of hospitalization and mortality.
- Diabetes diagnosis soon followed by heart failure could boost death riskon June 24, 2020 at 12:35 pm
For people with newly diagnosed Type 2 diabetes, heart failure posed the greatest five-year risk of death, more than any other heart or kidney disease, according to new research. The study, published ...
- Heart Disease, High BP Linked to Recovered Covid-19 Patients Testing Positive Again: Studyon June 24, 2020 at 4:48 am
Researchers from Huazhong University of Science and Technology in China assessed data on 938 COVID-19 patients from the country's Wuhan Union Hospital.
- This New App Analyzes Your Voice Quality To Diagnose Congestive Heart Failure: Can It Help With Covid-19?on June 23, 2020 at 3:58 pm
A new app developed by an Israeli biotech startup has shown promise in evaluating voice quality to detect buildup of fluid in the lungs, an important finding associated with congestive heart failure ...
- More young Americans developing unhealthy predictors of heart diseaseon June 23, 2020 at 1:58 pm
A new study finds that 1 in 5 people under age 40 now have metabolic syndrome, a group of risk factors that together increase the odds for many serious conditions, including diabetes, heart disease ...
- T2D Plus Heart Failure Packs a Deadly Punchon June 23, 2020 at 12:59 pm
Patients with incident type 2 diabetes who soon after also had heart failure appear faced a dramatically elevated mortality risk, a recent analysis found.
- Experts Warn Healthy People Against Taking Aspirin Daily To Prevent Heart Diseaseon June 23, 2020 at 4:48 am
Taking low-dose aspirin daily to prevent heart disease may not be very healthy after all, a recent review finds.
- Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki diseaseon June 23, 2020 at 2:19 am
This study was to investigate the correlation of vagal activity with coronary artery lesion (CAL) in Kawasaki disease (KD) children, and assess the predictive value of heart rate deceleration capacity ...
via Bing News